Literature DB >> 11204080

Reversal of deteriorated fractal behavior of heart rate variability by beta-blocker therapy in patients with advanced congestive heart failure.

L Y Lin1, J L Lin, C C Du, L P Lai, Y Z Tseng, S K Huang.   

Abstract

INTRODUCTION: The slope of the power spectrum in heart rate variability (HRV) reflects the fractal or scaling behavior in HR dynamics and recently was confirmed as an independent predictor of postmyocardial infarction survival. Whether or not the new measurement in HRV foresees the functional evolution in patients with advanced congestive heart failure treated by beta blockers is unclear. METHODS AND
RESULTS: Sequential 24-hour Holter ECG recordings were obtained at baseline, and 1 and 3 months after addition of atenolol therapy for advanced congestive heart failure in 10 patients. The slope and intercept of the regression line of power-law behavior, the short- and intermediate-term of detrended fluctuated analysis (DFA), the approximate entropy (ApEn), and the standard frequency spectra of the 24-hour HRV were compared sequentially as well as with those in 12 age-matched normal controls. The results showed that the slope (-1.70 +/- 0.45 vs -1.22 +/- 0.21; P < 0.05) and the intercept (5.11 +/- 0.46 vs 5.62 +/- 0.24; P < 0.05) of the regression line of power-law behavior and the short-term DFA (for 4 to 11 beats) (0.78 +/- 0.18 vs 1.13 +/- 0.21; P < 0.05) increased after 3 months of atenolol treatment. However, the change in intermediate-term DFA (>11 beats) and ApEn was not apparent (1.24 +/- 0.21 vs 1.22 +/- 0.15 and 1.34 +/- 0.14 vs 1.36 +/- 0.11; both P > 0.05). The evolution of the slope or intercept of the regression line of the HRV power spectrum did not correlate with the echocardiographic or clinical cardiac function, or with the frequency spectral components of the HRV (P > 0.05).
CONCLUSION: Additional beta-blocker therapy upregulated the fractal behavior control of the HRV in patients with advanced congestive heart failure. The improvement was independent of subjective and objective global cardiac performance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204080     DOI: 10.1046/j.1540-8167.2001.00026.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  21 in total

Review 1.  Heart rate variability and cardiovascular mortality.

Authors:  Rollo P Villareal; Brant C Liu; Ali Massumi
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

2.  Heart rate variability: recent developments.

Authors:  Juha S Perkiömäki
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-04       Impact factor: 1.468

3.  Influence of atropine on fractal and complexity measures of heart rate variability.

Authors:  Juha S Perkiomaki; Wojciech Zareba; Fabio Badilini; Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

4.  Nonlinear measures of heart rate variability and mortality risk in hemodialysis patients.

Authors:  Mari Suzuki; Takahashi Hiroshi; Toru Aoyama; Miho Tanaka; Hideki Ishii; Masaya Kisohara; Narushi Iizuka; Toyoaki Murohara; Junichiro Hayano
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-21       Impact factor: 8.237

5.  Linkages between anxiety and outcomes in heart failure.

Authors:  Marla J De Jong; Misook L Chung; Jia-Rong Wu; Barbara Riegel; Mary Kay Rayens; Debra K Moser
Journal:  Heart Lung       Date:  2011-03-30       Impact factor: 2.210

6.  Effects of carvedilol on heart rate dynamics in patients with congestive heart failure.

Authors:  Mustafa Ridha; Timo H Mäkikallio; Gustavo Lopera; Juan Pastor; Eduardo de Marchena; Simon Chakko; Heikki V Huikuri; Agustin Castellanos; Robert J Myerburg
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-04       Impact factor: 1.468

7.  The fractal-like complexity of heart rate variability beyond neurotransmitters and autonomic receptors: signaling intrinsic to sinoatrial node pacemaker cells.

Authors:  Yael Yaniv; Alexey E Lyashkov; Edward G Lakatta
Journal:  Cardiovasc Pharm Open Access       Date:  2013-08-27

Review 8.  Bench-to-bedside review: Beta-adrenergic modulation in sepsis.

Authors:  Etienne de Montmollin; Jerome Aboab; Arnaud Mansart; Djillali Annane
Journal:  Crit Care       Date:  2009-10-23       Impact factor: 9.097

9.  Deterministic chaos and fractal complexity in the dynamics of cardiovascular behavior: perspectives on a new frontier.

Authors:  Vijay Sharma
Journal:  Open Cardiovasc Med J       Date:  2009-09-10

10.  Search for HRV-parameters that detect a sympathetic shift in heart failure patients on β-blocker treatment.

Authors:  Yanru Zhang; Olav R de Peuter; Pieter W Kamphuisen; John M Karemaker
Journal:  Front Physiol       Date:  2013-04-16       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.